Acute care utilization among individuals with sickle cell disease and related cardiopulmonary and renal complications

PLoS One. 2024 Apr 16;19(4):e0297469. doi: 10.1371/journal.pone.0297469. eCollection 2024.

Abstract

Cardiopulmonary and renal end organ (CPR) complications are associated with early mortality among individuals with sickle cell disease (SCD). However, there is limited knowledge regarding acute care utilization for individuals with SCD and CPR complications. Our objective was to determine the prevalence of CPR complications in a state specific SCD population and compare acute care utilization among individuals with and without CPR complications. We leveraged 2017-2020 data for individuals with SCD identified by the Sickle Cell Data Collection program in Wisconsin. The prevalence of CPR complications is determined for distinct age groups. Generalized linear models adjusted for age compared the rate of acute care visits/person/year among individuals who had cardiopulmonary only, renal only, both cardiopulmonary and renal, or no CPR complications. There were 1378 individuals with SCD, 52% females, mean (SD) age 28.3 (18.5) years; 48% had at least one CPR complication during the study period. The prevalence of CPR complications was higher in adults (69%) compared to pediatric (15%) and transition (51%) groups. Individuals with SCD and cardiopulmonary complications had higher acute visit rates than those without CPR complications (5.4 (IQR 5.0-5.8) vs 2.4 (IQR 2.1-2.5), p <0.001)). Acute care visit rates were similar between individuals with SCD who had renal only complications and no CPR complications (2.7 (IQR 2.5-3.0) vs 2.4 (2.1-2.5), p = 0.24). The high acute care visit rates, especially for those with cardiopulmonary complications, warrant further investigation to understand risk factors for CPR complications, the underlying reasons and identify effective disease management strategies.

MeSH terms

  • Adult
  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / epidemiology
  • Anemia, Sickle Cell* / therapy
  • Child
  • Critical Care
  • Disease Management
  • Female
  • Humans
  • Kidney
  • Male
  • Wisconsin

Grants and funding

A part of the effort for Ashima Singh, Mahua Dasgupta and Amanda Brandow is funded by the Centers for Disease Control and Prevention: CDC-RFA-DD20-2003, Sickle Cell Data Collection.